New TB tests and drugs remain out of reach
- resisttb
- Feb 7, 2021
- 1 min read
A new report on accessibility to treatment for tuberculosis from Médecins Sans Frontières highlights persistent inequalities at global level. Read the article below.
top of page
Search
Recent Posts
See AllNew data from a phase II trial showed that sorfequiline showed greater activity against drug-susceptible TB compared to existing treatments at 8 weeks in addition to a more favorable safety profile. T
MDR/RR-TB has been decreasing globally since 2015, with the estimated number of people who have developed MDR-TB in 2024 at 390,000. Regionally, the number of people who developed MDR-TB (incident cas
The lowest cost of the full BPaLM regimen, which is the most recommended treatment for drug resistant tuberculosis (DR-TB), has now...
bottom of page
Comments